首页> 外文期刊>CNS oncology. >Development of CNS metastases in breast cancer patients treated with curative intent: a case–control study
【24h】

Development of CNS metastases in breast cancer patients treated with curative intent: a case–control study

机译:用治疗意图治疗乳腺癌患者CNS转移的发展:一种案例对照研究

获取原文
       

摘要

Background: The aim of this study was to identify risk factors that may predispose breast cancer patients to the development of CNS metastases. Materials & methods: We conducted a matched case–control study of breast cancer patients treated with surgery with curative intent. A total of?71 cases and 71 controls were analyzed, matched by year of surgery. Results: In our multivariable model, positive lymph node status (odds ratio [OR]: 5.08; CI: 2.04–12.65), the use of neoadjuvant chemotherapy (OR: 6.02; CI: 2.06–17.57) and triple-negative breast cancer (OR: 5.44; CI: 1.99–14.90) were statistically significant predictors of the development of CNS metastases. Conclusion: Women with certain risk factors have an increased odds of developing CNS metastases and evaluation of utility in brain metastases screening should be considered.
机译:背景:本研究的目的是识别可能使乳腺癌患者促进患有CNS转移的危险因素。材料与方法:我们对治疗意图治疗的手术治疗的乳腺癌患者的匹配病例对照研究。共分析了71例和71例,符合手术年份。结果:在我们的多变量模型,阳性淋巴结状态(差距[或]:5.08; CI:2.04-12.65),使用Neoadjuvant化疗(或:6.02; CI:2.06-17.57)和三阴性乳腺癌(或者:5.44; CI:1.99-14.90)是CNS转移的发展的统计显着预测因子。结论:具有一定风险因素的妇女在开发CNS转移的几率增加,应考虑脑转移筛选的效用的评估。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号